نتائج البحث - "Prognostic markers"

المساهمون: UCL - SSS/LDRI - Louvain Drug Research Institute, UCL - SSS/IREC - Institut de recherche expérimentale et clinique, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie

المصدر: Scientific Reports, Vol. 11, no.1, p. 9922 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Scientific reports, Vol. 11, no.1, p. 9922 (2021)
Scientific Reports

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, medicine.medical_specialty, Cancer therapy, medicine.medical_treatment, Science, Adipokine, Breast Neoplasms, Logistic regression, Article, Body Mass Index, 03 medical and health sciences, Prognostic markers, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Breast, Obesity, Mastectomy, Aged, Retrospective Studies, Chemotherapy, Multidisciplinary, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, Neoadjuvant Therapy, Apelin, 030104 developmental biology, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Cohort, Medicine, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35372ef1914ecbf55b5af41fe3b7fce3Test
https://hdl.handle.net/2078.1/248287Test

5

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

المساهمون: University of Zurich, Guberina, Maja

المصدر: Pharmacogenomics Journal 21(2021), 37-46
Pharmacogenomics J. 21, 37-46 (2021)
The Pharmacogenomics Journal

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_treatment, Medizin, Prognostic markers, 0302 clinical medicine, Genotype, Medicine, Cancer genetics, Aged, 80 and over, Hazard ratio, Chemoradiotherapy, Middle Aged, Prognosis, 10044 Clinic for Radiation Oncology, ddc, 3004 Pharmacology, 030220 oncology & carcinogenesis, Molecular Medicine, Biomarker (medicine), Female, medicine.drug, Adult, medicine.medical_specialty, 610 Medicine & health, Single-nucleotide polymorphism, Polymorphism, Single Nucleotide, Article, Disease-Free Survival, 03 medical and health sciences, 1311 Genetics, Internal medicine, Genetics, Humans, Genetic Association Studies, Aged, Xeroderma Pigmentosum Group D Protein, Pharmacology, Cisplatin, Chemotherapy, business.industry, Squamous Cell Carcinoma of Head and Neck, Cancer, Correction, medicine.disease, 030104 developmental biology, 1313 Molecular Medicine, ERCC2, Neoplasm Recurrence, Local, business

وصف الملف: application/pdf; s41397-020-0174-1.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd459ae3d56dd8fa4fce2b454e6f4347Test
https://www.ncbi.nlm.nih.gov/pubmed/32546699Test

6

Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma

المؤلفون: Naoto Gotohda, Soichiro Morinaga, Hirochika Toyama, Satoshi Okubo, Genichiro Ishii, Masayoshi Hioki, Motohiro Kojima, Yoko Matsuda, Yasuhiro Shimizu, Mari Mino-Kenudson, Shinichiro Takahashi, Katsuhiko Uesaka

المصدر: Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Multivariate analysis, Neoplasm, Residual, Lymphovascular invasion, medicine.medical_treatment, Perineural invasion, lcsh:Medicine, Adenocarcinoma, Article, Disease-Free Survival, Pancreaticoduodenectomy, 03 medical and health sciences, Prognostic markers, 0302 clinical medicine, Internal medicine, medicine, Carcinoma, Humans, lcsh:Science, Pathological, Grading (tumors), Neoadjuvant therapy, Aged, Chemotherapy, Multidisciplinary, business.industry, lcsh:R, Middle Aged, medicine.disease, Prognosis, Neoadjuvant Therapy, Pancreatic Neoplasms, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Surgical oncology, Lymphatic Metastasis, lcsh:Q, 030211 gastroenterology & hepatology, Female, Neoplasm Recurrence, Local, business, Carcinoma, Pancreatic Ductal

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a3545b6ef07a499b0f9fc3240a4351Test
http://europepmc.org/articles/PMC6868132Test

7

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment

المؤلفون: Hisashi Motomura, Wataru Goto, Shinichiro Kashiwagi, Yuka Asano, Shuhei Tomita, Koji Takada, Masahiko Ohsawa, Katsuyuki Takahashi, Kosei Hirakawa, Masaichi Ohira, Tsutomu Takashima, Takaharu Hatano

المصدر: British Journal of Cancer

مصطلحات موضوعية: Cancer microenvironment, Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Lymphocyte, Triple Negative Breast Neoplasms, chemical and pharmacologic phenomena, 乳癌, re-biopsy, Article, Prognostic markers, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, breast cancer, Internal medicine, Biopsy, tumour-infiltranting lymphocytes, Tumor Microenvironment, medicine, Humans, Survival analysis, Aged, Retrospective Studies, Aged, 80 and over, Chemotherapy, Tumor microenvironment, medicine.diagnostic_test, business.industry, Hazard ratio, Retrospective cohort study, hemic and immune systems, Middle Aged, Prognosis, Survival Analysis, 030104 developmental biology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Biopsy, Large-Core Needle, Neoplasm Recurrence, Local, immune, business, tumour microenvironment

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6683b7aa006c3c40a6532f3e7b2efb20Test
https://dlisv03.media.osaka-cu.ac.jp/il/meta_pub/G0000438repository_15321827-119-572Test

8

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer

المؤلفون: Mark E. Sherman, Carlos Caldas, Douglas F. Easton, Jolanta Lissowska, Mustapha Abubakar, Fiona M. Blows, Paul D.P. Pharoah, Montserrat Garcia-Closas, Mitch Dowsett, Jonine D. Figueroa, H. Raza Ali

المساهمون: Figueroa, Jonine [0000-0002-5100-623X], Dowsett, Mitch [0000-0003-4122-744X], Apollo - University of Cambridge Repository

المصدر: Modern Pathology
Abubakar, M, Figueroa, J, Raza Ali, H, Blows, F, Lissowska, J, Caldas, C, Easton, D F, Sherman, M E, Garcia-Closas, M, Dowsett, M & Pharoah, P 2019, ' Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer ', Modern Pathology . https://doi.org/10.1038/s41379-019-0270-4Test

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8f8da94901fcb45ebeb627ac20aa6eTest
https://www.repository.cam.ac.uk/handle/1810/290923Test

9

SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment

المصدر: British Journal of Cancer

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Cancer Research, Nottingham Breast Cancer Research Centre, Anthracycline, Adolescent, medicine.medical_treatment, Breast Neoplasms, Predictive markers, Article, Disease-Free Survival, 03 medical and health sciences, Prognostic markers, Young Adult, 0302 clinical medicine, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Humans, Anthracyclines, Neoadjuvant therapy, Aged, Cell Nucleus, Oncogene Proteins, Chemotherapy, Molecular medicine, business.industry, Carcinoma, Ductal, Breast, Estrogen Receptor alpha, Combination chemotherapy, Middle Aged, medicine.disease, Prognosis, Neoadjuvant Therapy, Tamoxifen, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Adjuvant, medicine.drug

وصف الملف: PDF

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a32024bfaf02e3fad9261f7433216dTest

10

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

المؤلفون: Melisi, Davide, García-Carbonero, Rocío, Macarulla Mercadé, Teresa, Pezet, Denis, Deplanque, Gael, Fuchs, Martin, Trojan, Jorg, Oettle, Helmut, Kozloff, Mark, Cleverly, Ann, Smith, Claire, Estrem, Shawn T., Gueorguieva, Ivelina, Lahn, Michael M. F., Blunt, Al, Benhadji, Karim A., Tabernero, Josep, Universitat Autònoma de Barcelona

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
British Journal of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Durvalumab, medicine.medical_treatment, Cancer immunotherapy, Deoxycytidine, Placebos, Prognostic markers, chemistry.chemical_compound, 0302 clinical medicine, Transforming Growth Factor beta, Antineoplastic Combined Chemotherapy Protocols, Tumor, Middle Aged, Tolerability, 030220 oncology & carcinogenesis, Quinolines, Female, Drug, medicine.drug, Signal Transduction, Adult, medicine.medical_specialty, Predictive markers, Article, Dose-Response Relationship, 03 medical and health sciences, Internal medicine, Pancreatic cancer, Biomarkers, Tumor, medicine, Galunisertib, Humans, Aged, Chemotherapy, Dose-Response Relationship, Drug, business.industry, Metastatic Pancreatic Adenocarcinoma, medicine.disease, Gemcitabine, Pancreatic Neoplasms, 030104 developmental biology, chemistry, Pyrazoles, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6056e8e1cf2ca16dcf9701e452111afTest
http://hdl.handle.net/11562/1014026Test

تنقيح النتائج